2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization …

M Glikson, JC Nielsen, MB Kronborg, Y Michowitz… - EP …, 2022 - academic.oup.com
for digital applications (smartphones, etc.). These versions are abridged and thus, for more
detailed information, the user should always access to the full text version of the guidelines …

Economic significance of biofilms: a multidisciplinary and cross-sectoral challenge

M Cámara, W Green, CE MacPhee… - npj Biofilms and …, 2022 - nature.com
The increasing awareness of the significance of microbial biofilms across different sectors is
continuously revealing new areas of opportunity in the development of innovative …

European Heart rhythm association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections …

C Blomström-Lundqvist, V Traykov… - European Journal of …, 2020 - academic.oup.com
Pacemakers, implantable cardiac defibrillators, and cardiac resynchronization therapy
devices are potentially life-saving treatments for a number of cardiac conditions, but are not …

Wearable and implantable devices for cardiovascular healthcare: from monitoring to therapy based on flexible and stretchable electronics

YJ Hong, H Jeong, KW Cho, N Lu… - Advanced Functional …, 2019 - Wiley Online Library
Cardiovascular disease is the leading cause of death and has dramatically increased in
recent years. Continuous cardiac monitoring is particularly important for early diagnosis and …

Challenges in infective endocarditis

TJ Cahill, LM Baddour, G Habib, B Hoen… - Journal of the american …, 2017 - jacc.org
Infective endocarditis is defined by a focus of infection within the heart and is a feared
disease across the field of cardiology. It is frequently acquired in the health care setting, and …

Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis

KA Polyzos, AA Konstantelias, ME Falagas - Ep Europace, 2015 - academic.oup.com
Infectious complications after cardiac implantable electronic device (CIED) implantation are
increasing over time and are associated with substantial mortality and healthcare costs. The …

Arrhythmia risk stratification of patients after myocardial infarction using personalized heart models

HJ Arevalo, F Vadakkumpadan, E Guallar… - Nature …, 2016 - nature.com
Sudden cardiac death (SCD) from arrhythmias is a leading cause of mortality. For patients at
high SCD risk, prophylactic insertion of implantable cardioverter defibrillators (ICDs) reduces …

Incidence of device-related infection in 97 750 patients: clinical data from the complete Danish device-cohort (1982–2018)

T Olsen, OD Jørgensen, JC Nielsen… - European heart …, 2019 - academic.oup.com
Aims Device-related infection (DRI) is a severe complication to cardiac implantable
electronic devices (CIED) therapy. Device-related infection incidence and its risk factors …

Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the …

JAT Sandoe, G Barlow, JB Chambers… - Journal of …, 2015 - academic.oup.com
Infections related to implantable cardiac electronic devices (ICEDs), including pacemakers,
implantable cardiac defibrillators and cardiac resynchronization therapy devices, are …

Next-generation pacemakers: from small devices to biological pacemakers

E Cingolani, JI Goldhaber, E Marbán - Nature Reviews Cardiology, 2018 - nature.com
Electrogenesis in the heart begins in the sinoatrial node and proceeds down the conduction
system to originate the heartbeat. Conduction system disorders lead to slow heart rates that …